HealthSouth Corp. (NYSE:HLS) issued an update on its FY16 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $2.44-2.56 for the period, compared to the Thomson Reuters consensus estimate of $2.46. The company issued revenue guidance of $3.6-3.7 billion, compared to the consensus revenue estimate of $3.68 billion.
Shares of HealthSouth Corp. (NYSE:HLS) traded down 0.79% during midday trading on Thursday, hitting $40.04. 1,148,404 shares of the stock traded hands. HealthSouth Corp. has a 12-month low of $30.26 and a 12-month high of $48.37. The stock has a market cap of $3.60 billion and a price-to-earnings ratio of 19.35. The company’s 50 day moving average price is $39.93 and its 200-day moving average price is $37.54.
HealthSouth Corp. (NYSE:HLS) last posted its earnings results on Thursday, July 28th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.60 by $0.09. The firm had revenue of $920.70 million for the quarter, compared to analysts’ expectations of $906.67 million. During the same period last year, the firm earned $0.47 earnings per share. HealthSouth Corp.’s revenue for the quarter was up 20.4% compared to the same quarter last year. On average, equities research analysts expect that HealthSouth Corp. will post $2.46 EPS for the current year.
A number of research firms recently issued reports on HLS. Barclays PLC lifted their price target on shares of HealthSouth Corp. from $39.00 to $45.00 and gave the company an equal weight rating in a research note on Thursday, April 28th. Mizuho lifted their price target on shares of HealthSouth Corp. from $40.00 to $47.00 and gave the company a buy rating in a research note on Friday, April 29th. Robert W. Baird reissued a buy rating on shares of HealthSouth Corp. in a research note on Monday, May 16th. Finally, Zacks Investment Research raised shares of HealthSouth Corp. from a hold rating to a buy rating and set a $46.00 price target on the stock in a research note on Wednesday, April 27th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the stock. The stock presently has an average rating of Buy and a consensus price target of $45.00.
In other news, insider Cheryl B. Levy sold 11,000 shares of the business’s stock in a transaction dated Friday, April 29th. The shares were sold at an average price of $41.44, for a total transaction of $455,840.00. Following the transaction, the insider now owns 97,513 shares of the company’s stock, valued at approximately $4,040,938.72. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.
